Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies

Abstract Background Metastatic uveal melanoma (mUM) is a rare malignancy and is different from metastatic cutaneous melanoma (mCM) in tumor characteristics and efficacy to immunotherapies. Tumor-specific biomarkers are required for mUM patients to monitor early disease progression on immunotherapies...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Devayani Machiraju, Christian H Ziener, Elena Clementi, Francisco García-Asencio, Jennifer Hüllein, Jasmin Richter, Bénédicte Lenoir, Melanie Wiecken, Daniel Hübschmann, Dirk Jäger, Jessica C Hassel
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMC 2025-07-01
श्रृंखला:	Journal of Experimental & Clinical Cancer Research
विषय:	Metastatic uveal melanoma Liver metastasis Biomarkers Immune checkpoint inhibitors Tebentafusp Liquid biopsy
ऑनलाइन पहुंच:	https://doi.org/10.1186/s13046-025-03451-2
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!